Searchable abstracts of presentations at key conferences in endocrinology

ea0032p1097 | Thyroid cancer | ECE2013

The role of radioiodine SPECT/CT in differentiated thyroid cancer

Mezosi Emese , Bajnok Laszlo , Rucz Karoly , Weninger Csaba , Schmidt Erzsebet , Szabo Zsuzsanna , Szekeres Sarolta , Zambo Katalin

Introduction: Beside remnant ablation and treatment of known metastases, radioiodine treatment of differentiated thyroid cancer is suitable for the discovery of unknown or suspected metastatic disease. In this study, the clinical utility of SPECT/CT, a hybrid imaging method was evaluated after radioiodine therapy.Patients and methods: Between July 2007 and March 2012, 260 investigations were performed at 188 patients. Male:female ratio was 47:141. Every ...

ea0020p99 | Thyroid | ECE2009

The prevalence and the significance of nodular thyroid disease (NTD) in thyroid autoimmune disease (TAD)

Zosin Ioana , Cornianu Marioara , Vlad Mihaela , Balas Melania , Golu Ioana , Amzar Daniela , Schmidt Roland

The aim of this study was to analyze retrospectively (2003–2007) the coexistence of NTD with TAD (Graves’ and Hashimoto’s diseases) in an iodine-replete area.The first study group included 381 cases with Graves’ hyperthyroidism, not previously treated with surgery or radioiodine therapy. The second group comprised 213 patients with hyperplasic Hashimoto’s disease and heterogeneous functionality.NTD was diag...

ea0011p914 | Thyroid | ECE2006

Expression and signal transduction of the cAMP-binding protein Epac in thyroid cells and thyroid tumors

Broecker-Preuss M , Sheu S-Y , Baten J , Bollepalli M , Schmidt M , Schmid KW , Mann K

cAMP signaling systems play a critical role in regulation of thyroid cell proliferation and function. Besides the well known protein kinase A (PKA) cascade, Epac (exchange protein directly activated by cAMP) depicts a novel effector of cAMP. Epac is directly activated by cAMP and in turn stimulates kinase cascades like Akt kinase, phospholipase Cε and MAP kinases as well as the Ras-like GTPases Rap1 and Rap2. As data about the impact of Epac on cAMP signaling of thyroid c...

ea0073pep6.3 | Presented ePosters 6: Calcium and Bone | ECE2021

Characterization of sarcopenia via different DXA derived indices and associations with uc-dpMGP

Schweighofer Natascha , Strasser Moritz , Haudum Christoph , Schmidt Albrecht , Kolesnik Ewald , Pieber Thomas , Obermayer-Pietsch Barbara

Sarcopenia is a degenerative loss of skeletal muscle mass, quality, and strength. It increases the risk of falls and fractures, is associated with cardiac and respiratory disease and cognitive impairment and leads to mobility disorders. It decreases quality of life, leads to loss of independence, placement in long-term care and finally death. A variety of indices and parameters can be used to define sarcopenia. According to literature, matrix-GLA-protein (MGP) is associated wi...

ea0090rc9.2 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Frequency of stress dose adjustment and adrenal crisis in children and adults with congenital adrenal hyperplasia

Tschaidse Lea , Wimmer Sophie , Auer Matthias , Lottspeich Christian , F. Nowotny Hanna , Dubinski Ilja , Schmidt Heinrich , Quinkler Marcus , Reisch Nicole

Background: Patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) require lifelong glucocorticoid replacement therapy, including stress dose adjustment to prevent life-threatening adrenal crises (AC). Previous studies indicate a high incidence of inadequate stress dose adjustment and AC in patients with CAH. The aim of this study was to prospectively assess AC incidence, frequency and details of stress dose adjustment as well as knowledge of the d...

ea0090p439 | Pituitary and Neuroendocrinology | ECE2023

Serial sampling of dried blood spots collected by a novel automated body-worn system, Fluispotter®

Krogh Jesper , Plomgaard Peter , Frikke-Schmidt Ruth , Velschow Sten , Johannesen Jesper , hilsted linda , Schroeder Malene , Feldt-Rasmussen Ulla

Repeated blood sampling is required in certain clinical and research settings, which is currently performed by drawing blood from venous catheters requiring manual handling of each sample at time of collection. A novel body-worn device for repeated serial samples, Fluispotter®, with automated extraction, collection and storage of up to 20 venous dried blood spot samples (DBS) over the course of 20 h may overcome problems with current methods for serial sampling. The purpo...

ea0063p163 | Diabetes, Obesity and Metabolism 1 | ECE2019

Diabetes-, sex-, and BMI specific associations of genetic variants in PRRG1 with cardiovascular surrogates in a large cohort at CV risk

Schweighofer Natascha , Haudum Christoph W , Schmidt Albrecht , Kolesnik Ewald , Colantonio Caterina R , Pieske Burkert , Pieber Thomas R , Obermayer-Pietsch Barbara

The proline rich and Gla domain genes PRRG1-4 encode for short transmembrane proteins. PRRG proteins contain a Gla domain with glutamic acid residues which are gamma-carboxylated in a vitamin-K-depend manner. In a previous study, we were able to show a decrease in PRRG1 gene expression during intima thickening in atherosclerosis. In this study, we investigated the association of single nucleotide polymorphisms (SNPs) in the vitamin-K-dependent protein PRRG1 with cardiovascular...

ea0063p209 | Diabetes, Obesity and Metabolism 1 | ECE2019

Insulin sensitivity and counter regulatory responses following hypoglycemia in healthy and type 1 diabetes patients

Bengtsen Mads Bisgaard , Stoy Julie , Rittig Nikolaj Fibiger , Voss Thomas Schmidt , Svart Mads Vandsted , Jessen Niels , Moller Niels

Background and aim: Insulin resistance is associated with type 2 diabetes and obesity but recent studies suggest that it may also be associated with type 1 diabetes (T1D), which may affect glycemic control. Hypoglycemia is a dreaded condition among patients with T1D and may also limit optimal glycemic management. We aimed to investigate insulin sensitivity and metabolic adaptions in healthy control subjects and T1D subjects.Material and methods: <!--SUB:...

ea0035oc1.3 | Thyroid clinical | ECE2014

Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)

Holmager Pernille , Schmidt Ulla , Dall Mark Peter , Dominguez Helena , Zerahn Bo , Raymond Ilan , Kistorp Caroline , Nygaard Birte , Faber Jens

Background and aim: Low T3 syndrome is associated with a poor prognosis in patients with chronic heart failure (CHF). It is controversial whether T3 treatment is indicated in CHF. A previous study using intravenous infusion of T3 for 72 h suggested a beneficial effect on cardiac performance.We aimed to evaluate the effect of 13 weeks of T3 treatment in patients with stable CHF on left ventricular ejection fraction (LVEF) compared to placebo.<p class=...

ea0070ep190 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Matrix–GLA–protein and cardiovascular parameters: uc–dp MGP vs total MGP

Schweighofer Natascha , Strasser Moritz , Haudum Christoph , Schmidt Albrecht , Kolesnik Ewald , Pieske Burkert , Pieber Thomas , Obermayer–Pietsch Barbara

Matrix–GLA–protein ( MGP), independent of its posttranslational modification(s), has been associated with bone parameters and cardiovascular risk in patients with and without type 2 diabetes mellitus (T2DM). We investigated whether uncarboxylated, dephosphorylated MGP (uc–dp MGP), total MGP or both are associated with anthropometric and cardiovascular parameters such as carotid to femoral pulse wave velocity (PWV), intima–media thickness (IMT) and relat...